Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis
Open Access
- 8 February 2010
- journal article
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 16
Abstract
No effective treatment for acute lung injury and fibrosis currently exists. Aim of this study was to investigate the time-dependent effect of bone marrow-derived mesenchymal stem cells (BMDMSCs) on bleomycin (BLM)-induced acute lung injury and fibrosis and nitric oxide metabolites and inflammatory cytokine production.Keywords
This publication has 47 references indexed in Scilit:
- The Role of Mesenchymal Stem Cells in the Functional Improvement of Chronic Renal FailureStem Cells and Development, 2009
- THE CRITICAL ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PULMONARY VASCULAR REMODELING AFTER LUNG INJURYShock, 2007
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Stem cells in the lung parenchyma and prospects for lung injury therapyEuropean Journal of Clinical Investigation, 2006
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Inducible Nitric Oxide Synthase, but Not Xanthine Oxidase, Is Highly Expressed in Interstitial Pneumonias and Granulomatous Diseases of Human LungAmerican Journal of Clinical Pathology, 2002
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001
- Mechanisms of bleomycin-induced lung damageArchives of Toxicology, 1991
- Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.Journal of Experimental Medicine, 1989